116 related articles for article (PubMed ID: 37984697)
1. Possible Regulation of P-Glycoprotein Function by Adrenergic Agonists II: Study with Isolated Rat Jejunal Sheets and Caco-2 Cell monolayers.
Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K
J Pharm Sci; 2024 May; 113(5):1209-1219. PubMed ID: 37984697
[TBL] [Abstract][Full Text] [Related]
2. Possible Regulation of P-glycoprotein Function by Adrenergic Agonists in a Vascular-luminal Perfused Preparation of Small Intestine.
Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K
J Pharm Sci; 2021 Dec; 110(12):3889-3895. PubMed ID: 34530005
[TBL] [Abstract][Full Text] [Related]
3. Effect of adrenergic stimulation on drug absorption via passive diffusion in Caco-2 cells.
Kimoto T; Takanashi M; Mukai H; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2009 Feb; 368(1-2):31-6. PubMed ID: 18977284
[TBL] [Abstract][Full Text] [Related]
4. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
5. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
6. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
7. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.
Zhao A; Mu H; Yao W; Chang X; Li W; Wang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):491-498. PubMed ID: 37385611
[TBL] [Abstract][Full Text] [Related]
9. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
Dunkoksung W; Vardhanabhuti N; Jianmongkol S
J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
[TBL] [Abstract][Full Text] [Related]
10. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
11. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Shaoyao Gancao Tang on function and expression of P-glycoprotein in Caco-2 cells].
Wang Y; Zhao J; Zhao Y; Li C; Yi Y; Liang A; Odd GN
Zhongguo Zhong Yao Za Zhi; 2012 Apr; 37(7):991-6. PubMed ID: 22792804
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
Hosoya KI; Kim KJ; Lee VH
Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
16. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
[TBL] [Abstract][Full Text] [Related]
17. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
19. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
20. [Copper treatment alters the barrier functions of human intestinal Caco-2 cells].
Liu ZW; Chen JL; Chen BH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):406-10. PubMed ID: 15569514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]